Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$178.43 USD
-0.90 (-0.50%)
Updated Oct 6, 2025 04:00 PM ET
After-Market: $178.42 -0.01 (-0.01%) 7:50 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
For Quest Diagnostics Incorporated, the company has a dividend yield of 1.78% compared to the Medical - Outpatient and Home Healthcare industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
DGX 178.43 -0.90(-0.50%)
Will DGX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for DGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DGX
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term
Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing
DGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
Other News for DGX
Quest Diagnostics: Investing In Healthcare's Future Today
Notable healthcare headlines for the week: Pfizer, Novo Nordisk and JNJ in focus
DGX forms 50 Day Moving Average Support on October 3
50 Day Moving Average Support appears for DGX after 0.89% move
Barclays Raises Price Target for Quest Diagnostics (DGX) to $190 | DGX Stock News